Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23625211.
- Also identified by DOI 10.1093/eurheartj/eht142.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In part II of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. Specifically, evidence-based cardiovascular therapies are discussed through novel clinical insights on management of hyperglycaemia, hypertension, dyslipidaemia as well as platelet dysfunction. Recent trends in the incidence and outcomes of vascular disease in diabetes suggest that timely and effective implementation of therapies is making a favourable impact.
Medical subject headings
- Diabetes Mellitus, Type 2
- Diabetic Angiopathies
- Platelet Aggregation Inhibitors